-
1
-
-
84858424089
-
Converting cancer therapies into cures: Lessons from infectious diseases
-
Glickman MS, Sawyers CL. Converting cancer therapies into cures: lessons from infectious diseases. Cell 2012;148:1089-98.
-
(2012)
Cell
, vol.148
, pp. 1089-1098
-
-
Glickman, M.S.1
Sawyers, C.L.2
-
2
-
-
84865480687
-
Nanotechnology-based combinational drug delivery: An emerging approach for cancer therapy
-
Parhi P, Mohanty C, Sahoo SK. Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy. Drug Discov Today 2012;17:1044-52.
-
(2012)
Drug Discov Today
, vol.17
, pp. 1044-1052
-
-
Parhi, P.1
Mohanty, C.2
Sahoo, S.K.3
-
3
-
-
0035869407
-
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2
-
DOI 10.1056/NEJM200103153441101
-
Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 2001;344:783-92. (Pubitemid 32222155)
-
(2001)
New England Journal of Medicine
, vol.344
, Issue.11
, pp. 783-792
-
-
Slamon, D.J.1
Leyland-Jones, B.2
Shak, S.3
Fuchs, H.4
Paton, V.5
Bajamonde, A.6
Fleming, T.7
Eiermann, W.8
Wolter, J.9
Pegram, M.10
Baselga, J.11
Norton, L.12
-
5
-
-
32944482677
-
Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer
-
DOI 10.1200/JCO.2005.04.937
-
Gradishar WJ, Tjulandin S, Davidson N, Shaw H, Desai N, Bhar P, et al. Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer. J Clin Oncol 2005;23:7794-803. (Pubitemid 46657376)
-
(2005)
Journal of Clinical Oncology
, vol.23
, Issue.31
, pp. 7794-7803
-
-
Gradishar, W.J.1
Tjulandin, S.2
Davidson, N.3
Shaw, H.4
Desai, N.5
Bhar, P.6
Hawkins, M.7
O'Shaughnessy, J.8
-
6
-
-
84885190174
-
New perspectives in nanomedicine
-
S0163-7258:00145-9
-
Thorley AJ, Tetley TD. New perspectives in nanomedicine. Pharmacol Ther 2013; S0163-7258:00145-9.
-
(2013)
Pharmacol Ther
-
-
Thorley, A.J.1
Tetley, T.D.2
-
7
-
-
84855837427
-
Curcumin nanoformulations: A future nanomedicine for cancer
-
Yallapu MM, Jaggi M, Chauhan SC. Curcumin nanoformulations: a future nanomedicine for cancer. Drug Discov Today 2012;17:71-80.
-
(2012)
Drug Discov Today
, vol.17
, pp. 71-80
-
-
Yallapu, M.M.1
Jaggi, M.2
Chauhan, S.C.3
-
8
-
-
80051487233
-
Advanced drug delivery systems of curcumin for cancer chemoprevention
-
Bansal SS, Goel M, Aqil F, Vadhanam MV, Gupta RC. Advanced drug delivery systems of curcumin for cancer chemoprevention. Cancer Prev Res 2011;4:1158-71.
-
(2011)
Cancer Prev Res
, vol.4
, pp. 1158-1171
-
-
Bansal, S.S.1
Goel, M.2
Aqil, F.3
Vadhanam, M.V.4
Gupta, R.C.5
-
9
-
-
78049442013
-
Delivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancer
-
Nair HB, Sung B, Yadav VR, Kannappan R, Chaturvedi MM, Aggarwal BB. Delivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancer. Biochem Pharmacol 2010; 80:1833-43.
-
(2010)
Biochem Pharmacol
, vol.80
, pp. 1833-1843
-
-
Nair, H.B.1
Sung, B.2
Yadav, V.R.3
Kannappan, R.4
Chaturvedi, M.M.5
Aggarwal, B.B.6
-
10
-
-
84863115216
-
Nanochemoprevention by encapsulation of (-)-epigallocatechin-3-gallate with bioactive peptides/chitosan nanoparticles for enhancement of its bioavailability
-
Camb
-
Hu B, Ting Y, Yang X, Tang W, Zeng X, Huang Q. Nanochemoprevention by encapsulation of (-)-epigallocatechin-3-gallate with bioactive peptides/chitosan nanoparticles for enhancement of its bioavailability. Chem Commun (Camb) 2012;48:2421-3.
-
(2012)
Chem Commun
, vol.48
, pp. 2421-2423
-
-
Hu, B.1
Ting, Y.2
Yang, X.3
Tang, W.4
Zeng, X.5
Huang, Q.6
-
11
-
-
84887905558
-
A novel combinatorial nanotechnology-based oral chemopreventive regimen demonstrates signi ficant suppression of pancreatic cancer neoplastic lesions
-
Grandhi BK, Thakkr A, Wang J, Prabhu S. A novel combinatorial nanotechnology-based oral chemopreventive regimen demonstrates signi ficant suppression of pancreatic cancer neoplastic lesions. Cancer Prev Res 2013;6:1015-25.
-
(2013)
Cancer Prev Res
, vol.6
, pp. 1015-1025
-
-
Grandhi, B.K.1
Thakkr, A.2
Wang, J.3
Prabhu, S.4
-
12
-
-
57349171371
-
Lipid nanoparticles with a solid matrix (SLN, NLC, LDC) for oral drug delivery
-
Muchow M, Maincent P, Muller RH. Lipid nanoparticles with a solid matrix (SLN, NLC, LDC) for oral drug delivery. Drug Dev Ind Pharm 2008;34:1394-405.
-
(2008)
Drug Dev Ind Pharm
, vol.34
, pp. 1394-1405
-
-
Muchow, M.1
Maincent, P.2
Muller, R.H.3
-
13
-
-
34250308874
-
Studies on oral absorption of stearic acid SLN by a novel fluorometric method
-
DOI 10.1016/j.colsurfb.2007.03.002, PII S0927776507001166
-
Yuan H, Chen J, Du YZ, Hu FQ, Zeng S, Zhao HL. Studies on oral absorption of stearic acid SLN by a novel fluorometric method. Colloids Surf B Biointerfaces 2007;58:157-64. (Pubitemid 46921452)
-
(2007)
Colloids and Surfaces B: Biointerfaces
, vol.58
, Issue.2
, pp. 157-164
-
-
Yuan, H.1
Chen, J.2
Du, Y.-Z.3
Hu, F.-Q.4
Zeng, S.5
Zhao, H.-L.6
-
14
-
-
0031782519
-
Solid lipid nanoparticles in lymph and plasma after duodenal administration to rats
-
DOI 10.1023/A:1011975120776
-
Bargoni A, Cavalli R, Caputo O, Fundaro A, Gasco MR, Zara GP. Solid lipid nanoparticles in lymph and plasma after duodenal administration to rats. Pharm Res 1998;15:745-50. (Pubitemid 28275652)
-
(1998)
Pharmaceutical Research
, vol.15
, Issue.5
, pp. 745-750
-
-
Bargoni, A.1
Cavalli, R.2
Caputo, O.3
Fundaro, A.4
Gasco, M.R.5
Zara, G.P.6
-
15
-
-
84855556537
-
Aspirin in the chemoprevention of colorectal neoplasia: An overview
-
Chan AT, Arber N, Burn J, Chia WK, Elwood P, Hull MA, et al. Aspirin in the chemoprevention of colorectal neoplasia: an overview. Cancer Prev Res 2012;5:164-78.
-
(2012)
Cancer Prev Res
, vol.5
, pp. 164-178
-
-
Chan, A.T.1
Arber, N.2
Burn, J.3
Chia, W.K.4
Elwood, P.5
Hull, M.A.6
-
16
-
-
84862248921
-
Cancer cell signaling pathways targeted by spice-derived nutraceuticals
-
Sung B, Prasad S, Yadav VR, Aggarwal BB. Cancer cell signaling pathways targeted by spice-derived nutraceuticals. Nutr Cancer 2012;64:173-97.
-
(2012)
Nutr Cancer
, vol.64
, pp. 173-197
-
-
Sung, B.1
Prasad, S.2
Yadav, V.R.3
Aggarwal, B.B.4
-
17
-
-
84874489560
-
Keap1-nrf2 signaling: A target for cancer prevention by sulforaphane
-
Kensler TW, Egner PA, Agyeman AS, Visvanathan K, Groopman JD, Chen JG, et al. Keap1-nrf2 signaling: a target for cancer prevention by sulforaphane. Top Curr Chem 2013;329:163-77.
-
(2013)
Top Curr Chem
, vol.329
, pp. 163-177
-
-
Kensler, T.W.1
Egner, P.A.2
Agyeman, A.S.3
Visvanathan, K.4
Groopman, J.D.5
Chen, J.G.6
-
18
-
-
84869783446
-
Chemoprevention of pancreatic cancer using solid-lipid nanoparticulate delivery of a novel aspirin, curcumin and sulforaphane drug combination regimen
-
Sutaria D, Grandhi BK, Thakkar A, Wang J, Prabhu S. Chemoprevention of pancreatic cancer using solid-lipid nanoparticulate delivery of a novel aspirin, curcumin and sulforaphane drug combination regimen. Int J Oncol 2012;41:2260-8.
-
(2012)
Int J Oncol
, vol.41
, pp. 2260-2268
-
-
Sutaria, D.1
Grandhi, B.K.2
Thakkar, A.3
Wang, J.4
Prabhu, S.5
-
19
-
-
84874740027
-
The molecular mechanism of action of aspirin, curcumin and sulforaphane combinations in the chemoprevention of pancreatic cancer
-
Thakkar A, Sutaria D, Grandhi BK, Wang J, Prabhu S. The molecular mechanism of action of aspirin, curcumin and sulforaphane combinations in the chemoprevention of pancreatic cancer. Oncol Rep 2013;29:1671-7.
-
(2013)
Oncol Rep
, vol.29
, pp. 1671-1677
-
-
Thakkar, A.1
Sutaria, D.2
Grandhi, B.K.3
Wang, J.4
Prabhu, S.5
-
20
-
-
84873330378
-
67-kDa laminin receptor increases cGMP to induce cancer-selective apoptosis
-
Kumazoe M, Sugihara K, Tsukamoto S, Huang Y, Tsurudome Y, Suzuki T, et al. 67-kDa laminin receptor increases cGMP to induce cancer-selective apoptosis. J Clin Invest 2013;123:787-99.
-
(2013)
J Clin Invest
, vol.123
, pp. 787-799
-
-
Kumazoe, M.1
Sugihara, K.2
Tsukamoto, S.3
Huang, Y.4
Tsurudome, Y.5
Suzuki, T.6
-
21
-
-
51049115143
-
Synergistic inhibition of lung tumorigenesis by a combination of green tea polyphenols and atorvastatin
-
Lu G, Xiao H, You H, Lin Y, Jin H, Snagaski B, et al. Synergistic inhibition of lung tumorigenesis by a combination of green tea polyphenols and atorvastatin. Clin Cancer Res 2008;14:4981-8.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 4981-4988
-
-
Lu, G.1
Xiao, H.2
You, H.3
Lin, Y.4
Jin, H.5
Snagaski, B.6
-
22
-
-
74049089011
-
Synergistic actions of atorvastatin with gamma-tocotrienol and celecoxib against human colon cancer HT29 and HCT116 cells
-
Yang Z, Xiao H, Jin H, Koo PT, Tsang DJ, Yang CS. Synergistic actions of atorvastatin with gamma-tocotrienol and celecoxib against human colon cancer HT29 and HCT116 cells. Int J Cancer 2010;126:852-63.
-
(2010)
Int J Cancer
, vol.126
, pp. 852-863
-
-
Yang, Z.1
Xiao, H.2
Jin, H.3
Koo, P.T.4
Tsang, D.J.5
Yang, C.S.6
-
23
-
-
84862646294
-
Chitosan-based drug nanocarriers: Where do we stand?
-
Garcia-Fuentes M, Alonso MJ. Chitosan-based drug nanocarriers: where do we stand? J Control Release 2012;161:496-504.
-
(2012)
J Control Release
, vol.161
, pp. 496-504
-
-
Garcia-Fuentes, M.1
Alonso, M.J.2
-
24
-
-
84872032765
-
Organ-specific exposure and response to sulforaphane, a key chemopreventive ingredient in broccoli: Implications for cancer prevention
-
Veeranki OL, Bhattacharya A, Marshall JR, Zhang Y. Organ-specific exposure and response to sulforaphane, a key chemopreventive ingredient in broccoli: implications for cancer prevention. Br J Nutr 2013;109:25-32.
-
(2013)
Br J Nutr
, vol.109
, pp. 25-32
-
-
Veeranki, O.L.1
Bhattacharya, A.2
Marshall, J.R.3
Zhang, Y.4
-
25
-
-
62549109060
-
Hepatotoxicity from green tea: A review of the literature and two unpublished cases
-
Mazzanti G, Menniti-Ippolito F, Moro PA, Cassetti F, Raschetti R, Santuccio C, et al. Hepatotoxicity from green tea: a review of the literature and two unpublished cases. Eur J Clin Pharmacol 2009;65:331-41.
-
(2009)
Eur J Clin Pharmacol
, vol.65
, pp. 331-341
-
-
Mazzanti, G.1
Menniti-Ippolito, F.2
Moro, P.A.3
Cassetti, F.4
Raschetti, R.5
Santuccio, C.6
-
26
-
-
72149118194
-
Hepatotoxicity of high oral dose (-)-epigallocatechin-3-gallate in mice
-
Lambert JD, Kennett MJ, Sang S, Reuhl KR, Ju J, Yang CS. Hepatotoxicity of high oral dose (-)-epigallocatechin-3-gallate in mice. Food Chem Toxicol 2010;48:409-16.
-
(2010)
Food Chem Toxicol
, vol.48
, pp. 409-416
-
-
Lambert, J.D.1
Kennett, M.J.2
Sang, S.3
Reuhl, K.R.4
Ju, J.5
Yang, C.S.6
|